Charlie

Goldsmith

For 18 years Charlie Goldsmith kept his healing ability out of the public eye. It has always been Charlie’s intention to expose his work to multiple scientific studies.

It wasn't until after his first hospital study, completed in 2013 by doctors at the NYU Lutheran hospital in New York, that it became public. The study was designed to build a case for a double blind study in the future. It was published in 2015.

In 2015, Charlie's clinical practises were again studied jointly by Monash University Professor Paul Komesaroff and the NYU Lutheran hospital. This study is currently being written and due to be submitted for publication in 2018.

In 2016 Professors at NYU Langone Hospital in New York approached Charlie to do a double blind controlled trial. It is currently going through the IRB approval process and is due to commence early 2018.

Charlie is also the subject of a USA television series called 'The Healer' on TLC which premiered November 6, 2017.

Pumpy Jackson

Most of our narcotics decrease a patient’s pain by 3 to 5 points. If you go from 10, meaning the worst pain you can imagine, to 5, that’s significant. In some cases Charlie reduced a patient’s pain from 10 to zero. He also treated people with infections where antibiotics were not effective. You could see the shift in a patient’s status from stagnant to a rapid healing resolution. I can’t quantify it, but I would say Charlie cut days off patients’ hospital stays. Watching him work has been humbling in the most extreme way.

— Dr. Ramsey Joudeh NYU Lutheran Medical Center NYC

The first day when we started one patient went from 8 to 3 on the pain scale, It was miraculous, within five seconds of Charlie closing his eyes, the patient reported the decrease in pain. What was really impressive was the speed and the size of the effects he had without touching patients or saying anything. Some colleagues were in disbelief. Some just smirked and moved on. Not everybody has seen what he can do.

I first met Charlie when I was a medical student at a community hospital in Brooklyn. When he first introduced himself and explained the nature of his work as a healer, I was admittedly skeptical. In medical school, our education is primarily based on western medicine and we were taught to approach any alternative with skepticism. As I spent time with Charlie and saw how successful he was with treating patients’ previously intractable pain, I became more and more accepting of his healing abilities as a substitute to pills and injections.

Currently, in the midst of an opioid epidemic, Charlie’s talents as a healer are more relevant than ever. As a practicing physician, I welcome this treatment option as a safer alternative to the current convention of pain management.